Information displayed below is a subset of the entire knowledge base and may be incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.

Description

Idarubicin is an anthracycline chemotherapy drug used to treat certain types of cancer, such as acute myeloid leukemia (AML). It works by interfering with the growth of cancer cells, which eventually leads to their death. Idarubicin is usually given in combination with other chemotherapy drugs.

Common side effects of idarubicin include nausea, vomiting, hair loss, mouth sores, fatigue, and an increased risk of infection. Other serious side effects may include low white blood cell counts, anemia, and heart problems.

Brand names associated with idarubicin include Idamycin, Idarubicin Hydrochloride, and Zavedos.

Synonyms

• idarubicin

Classifications

• anthracycline
• antibiotic
• antineoplastic
• cytotoxic

Detailed Disease Information (use the search buttons below to find details on these topics from other web sources)
All of the following must be considered when interpreting clinical findings and are too extensive to be covered on this site: